International Assets Investment Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$168K Buy
+4,421
New +$154K 0.01% 925
2024
Q3
Sell
-2,662
Closed -$72.5K 2039
2024
Q2
$72.5K Buy
+2,662
New +$71.3K 0.01% 1047
2021
Q3
Sell
-150,716
Closed -$4.37M 538
2021
Q2
$4.37M Buy
150,716
+75,551
+101% +$1.95M 0.81% 19
2021
Q1
$2.03M Buy
75,165
+54,274
+260% +$1.42M 0.19% 114
2020
Q4
$705K Buy
20,891
+1,277
+7% +$31.8K 0.13% 151
2020
Q3
$534K Buy
19,614
+2,530
+15% +$60.7K 0.13% 154
2020
Q2
$470K Buy
+17,084
New +$379K 0.11% 173

Other funds holding FTXH

International Assets Investment Management's FTXH Position: Q2 2026 in Review

International Assets Investment Management opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2026: 4,421 shares worth $168K. The stake represents 0.01% of the portfolio and ranks #925 among its holdings. This is a return to the name: International Assets Investment Management previously reported a position in FTXH as recently as Q2 2024.

International Assets Investment Management first reported a position in FTXH in Q2 2020 and has held it in 7 quarters since. The position peaked at $4.37M in Q2 2021. 11 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • International Assets Investment Management held 4,421 shares of First Trust Nasdaq Pharmaceuticals ETF worth $168K as of Q2 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new International Assets Investment Management position in Q2 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #925 holding.
  • International Assets Investment Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2020 and has held it in 7 quarters since.
  • International Assets Investment Management's First Trust Nasdaq Pharmaceuticals ETF position peaked at $4.37M in Q2 2021.
  • 11 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.